Friday, December 16, 2011

Lux Research Predicts Bio-based Chemicals & Materials Industry to Reach 19.7 USD B in 2016


Buoyed by consumer preferences, government mandate and corporate commitments, bio-based chemicals and materials will more than double capacity to 9.2 million tons, says Lux Research.

The bio-based chemicals and materials industry, carefully nurtured from labs to factories, has reached a tipping point and capacity will double in market potential to $19.7 billion in 2016, as its global manufacturing capacity zooms 140%, according to a recent report by Lux Research.
The global capacity for 17 major bio-based materials doubled to 3.8 million tons this year, but over the next five years will climb to 9.2 million tons, bringing critical scale to an industry poised to revolutionize the chemicals market, said the report, titled, "Global Bio-based Chemical Capacity Springs to Scale."
"Several strong forces consumer preference, corporate commitment, and government mandates and support are driving development in this space." said Kalib Kersh, Lux Research Analyst and lead author of the report. "For an industry with the scale of plastics, polymers, and chemicals, no business issue is as big as that of capacity. For bio-based alternatives to compete with petroleum, they have to match billion-dollar businesses producing at megaton levels," he added.
Lux analysts tallied up the capacity of 151 identified global facilities and captured their intended operational dates, products and capacities, and added 87 additional facilities for which it made conservative estimates. Among Lux Research's other key findings:
  • Bioplastics steal the scene but will slow down. From 2006 to 2011, bioplastics have experienced explosive growth of 1,500% to a current aggregate capacity of 470,000 tons, and a 10.9% share of all bio-based materials. Expansion is expected to moderate, though their capacity will still grow 57% from 2011 to 2016.



  • Cellulose polymers and starch-based plastics dominant. Cellulose polymers and starch-derived materials still rule because they are durable, strong and easily biodegradable: They've been widely used in high-performance plastic coatings, buttons and yarns, and even early LEGO bricks. However, their share of total capacity will slide from 45% in 2011 to 21% in 2016.



  • Consolidation ahead. By 2016, there will be consolidation both within sectors of bio-based materials manufacturing, and regionally, as leaders buy up technologies and access to feedstock. Momentum derived from existing capacity ethanol from sugarcane ethanol being converted to ethylene and propylene, for instance will influence regional specialization.

  • Saturday, December 10, 2011

    Evonik's PMMA Solar Fresnel lens Finds Use in Large-scale Concentrating Photovoltaics


    Experts estimated the world's installed capacity for concentrating photovoltaics (CPV) at 23 megawatts in 2010. The market research company GTM Research expects annual demand to rise to more than a gigawatt by 2015. Gone are the days of small pilot plants. Forecasts in particular underline the increasing importance of CPV.
    But a major prerequisite for building the solar panels is a supply of the required high-quality lenses. "We supplied PLEXIGLAS® Solar Fresnel lens parquets for over 10 MW of electricity from concentrating photovoltaics in 2011 already," says Uwe Loffler, who is responsible for the Solar Market Segment at the Acrylic Polymers Business Line of Evonik Industries. "That proved we can produce lenses for multi-megawatt projects."
    PLEXIGLAS® is used for the primary lenses in the solar panels. These high-quality lens parquets can be supplied with an edge length in excess of one meter. Customers have confirmed the optical efficiency of over 87%. The key properties in this respect are high light transmission and the outstandingly accurate mold surface reproduction of the high-precision Fresnel structures. Added to this is the longevity of the material that retains its excellent transparency even in permanent use.
    Evonik Industries is a worldwide manufacturer of PMMA products sold under the PLEXIGLAS® trademark on the European, Asian, African and Australian continents and under the trademark ACRYLITE® in the Americas.

    Thursday, December 8, 2011

    Arizona Researchers to Widen Methods for Producing Bio-based Styrene


    Styrene is one of the major building-block chemicals used to make many of the rubbery polymers and plastic materials we use today. More than 6 billion tons of it is manufactured each year in the United States alone, most of which goes into producing insulating materials, automobile tires, footwear, medical devices and hundreds of other widely used products. The problem is that all styrene is currently derived from a dwindling resource petroleum and its production requires one of the most energy-intensive processes in the petrochemical manufacturing industry. More than three metric tons of steam is necessary to produce just one metric ton of styrene. That excessive energy consumption also produces significant amounts of carbon dioxide, contributing to the detrimental buildup of greenhouses gases in the atmosphere.

    At Arizona State University, David Nielsen and Rebekah McKenna are seeking ways to make styrene and other common petrochemicals using renewable resources. They want to produce materials that are more sustainable, require less energy to produce, and alleviate negative environmental impacts when they are manufactured. Nielsen is an assistant professor of Chemical Engineering in the School for Engineering of Matter, Transportation and Energy, one of ASU's Ira A. Fulton Schools of Engineering. McKenna is studying to earn a doctoral degree in chemical engineering. They're experimenting with engineering microorganisms to act as catalysts for making styrene from renewable resources in this case biological materials, like sugars from plants.

    The bacteria they have genetically engineered for that purpose has drawn attention from peers in their field. A report on their work was first published in the international science and engineering journal Metabolic Engineering, and then later appeared in Nature Chemical Biology as a featured "research highlight". This past summer, McKenna was one of only a handful of student researchers selected by the Society for Industrial Microbiology to give a presentation at its annual meeting. Her report, "Styrene Biosynthesis from Renewable Resources," earned the conference's Best Student Oral Presentation award. "What we've done is create a new metabolic pathway," Nielsen explains. "We've found the particular genes and enzymes required to achieve the necessary chemistry, and we have strung them together in a way that enables our engineered bacteria to function as a sort of biological catalyst. In this way the cells can perform all of the biochemical reactions required to convert sugars like glucose into styrene".
    He and McKenna are doing what he describes as building "microscopic microbial chemical factories," designed to synthesize the raw ingredients required to make products with characteristics identical to those that in the past have been derived only from petroleum. If that is achieved, it could be possible for these chemicals produced from renewable materials to "plug directly into existing infrastructure, and be ready to use in current manufacturing systems that provide many of the products we use every day," Nielsen says.

    The next leap a particularly challenging one involves further improving the bacteria and scaling up the process to where styrene yields can be produced from renewable resources in as economically viable a way as styrene made from petroleum. Nielsen sees potential for his and McKenna's research to contribute to engineering efforts to develop other commonly used chemicals, fuels, and materials from renewable resources that would "create whole new markets for renewable biochemicals and biopolymers". At the very least, "we hope to be able to develop viable renewable alternatives for the bio-plastics industry," he says. "From there, we might be able to begin making all sorts of new products from renewable, biological materials," including new kinds of fuels.

    Monday, December 5, 2011

    Molecular Solar's Organic Photovoltaics Used for Charging Electronic Device Shines at Lord Stafford Awards


    Molecular Solar is pioneering ultra-thin, flexible solar panels that can be used in portable chargers for mobile phones and other handheld devices, allowing devices to be recharged without needing to be connected to a mains power supply. As well as being a convenient way to charge electronic equipment, the technology will also help to reduce an individual's carbon footprint.
    The Lord Stafford Awards showcase collaboration between business and academia in the Midlands and Molecular Solar was recognised for its very successful partnership with Warwick Ventures, the University of Warwick's technology commercialisation company.
    Warwick Ventures helped set the company up in 2008 and has been instrumental in securing funding to enable Molecular Solar to translate the research done in the University's Department of Chemistry into marketable products.
    Most recently, Molecular Solar announced that its solar cells, which are made from organic photovoltaic materials, can now produce voltages of over 4 volts, making its technology suitable for recharging the lithium ion batteries used in many handheld devices. This means the cells are now ready to be developed for commercial use.
    Professor Shipman says: "Molecular Solar is founded on the strength of its partnerships with Warwick Ventures, the University of Warwick's Department of Chemistry, and other companies with whom we are working closely. We are delighted that the success of those partnerships has been recognised by the Lord Stafford team."
    Quentin Compton Bishop, CEO of Warwick Ventures, says: "Warwick Ventures has spun out more than 50 companies over the past 11 years and it is always a great honour to be recognised in the Lord Stafford Awards. We are delighted with Molecular Solar's achievement and look forward to working with them as they continue to grow and develop a truly groundbreaking technology."

    PolyOne Utilizes Sanitized's Antimicrobial Solutions to Produce Medical Device for Healthcare Applications


    PolyOne Corporation, a premier global provider of specialized polymer materials, services and solutions, announced an alliance with Sanitized AG, one of the leading producers of antimicrobials with over 50 years of experience, to provide innovative, customizable polymer solutions for specialized healthcare and medical device applications.
    PolyOne will utilize Sanitized® MedX antimicrobials in select formulations of WithStand™ Antimicrobial Solutions, which consist of active ingredients developed using proprietary technology that helps to inhibit the growth of bacteria, viruses and fungi on plastic surfaces.
    "PolyOne continues to align with leading global and innovative companies that help us better serve our customers," said Craig M. Nikrant, Senior Vice President and President, Global Specialty Engineered Materials, PolyOne Corporation. "This alliance gives Sanitized the benefit of PolyOne's expertise in medical polymer formulation and our penetration in the healthcare market. In turn, PolyOne gains from Sanitized's unique bacteria protection technology."
    PolyOne WithStand™ solutions are ideal for healthcare applications, such as minimally invasive surgical device housings, respiratory and anesthesia devices, catheters, hospital furnishings and medical packaging.

    Sequana Selects Evonik's PEEK to Design its Pump Implant for Medical Applications

    The newly-developed ALFAPump™ System from Sequana Medical Switzerland helps patients suffering from excessive fluid in their abdomen: the battery-operated pump implant is based on the PEEK polymer VESTAKEEP® from Evonik Industries and has received CE approval. It pumps the excessive fluid from the abdominal cavity into the bladder, from which it can be excreted by the patient in the natural manner. Up to now, the water has had to be drained using painful paracentesis during regular doctor's appointments. Patients with liver disorders, congestive heart failure and certain types of cancer are particularly affected by ascites. The new system consists of a subcutaneously implanted pump and a catheter system: one catheter connects the abdomen to the pump, while the second connects the pump to the bladder.


    The new technology is made possible thanks to the use of VESTAKEEP® PEEK, a polyether ether ketone which is particularly characterized by its biocompatibility and biostability. In contrast to metal, the ion content of VESTAKEEP® PEEK is virtually zero, thus preventing shift reactions with the body. What's more, the PEEK implant is considerably lighter than a comparable metal implant. The VESTAKEEP® PEEK iGrades are specifically suited to long-term use in the human body and can also be made transparent to X-ray on request, so that they cannot be seen on X-rays.



    "The ALFAPump™ System not only improves the quality of life for patients but also represents a cost-effective solution," explains Dr. Noel Johnson, CEO at Sequana Medical. Marc Knebel, Business Management Director at VESTAKEEP® Medical & Implants, adds:
    "The ALFAPump™ System is a perfect example of the many benefits of PEEK compared to metal in this field. Other areas, such as spinal implants, can also benefit from these advantages."
    The high processability of PEEK is a further advantage of its use: VESTAKEEP® PEEK polymer can be manufactured using either the injection molding or cutting procedures, thereby supporting freedom of design in the development of new implant technology.



    Saturday, December 3, 2011

    Teijin to Open CFRTP Pilot Plant for Producing Composites from Carbon Fiber for Japan's Automotive Industry


    Teijin Limited has announced that it will establish the world's first pilot plant for fully integrated production of carbon fiber reinforced thermoplastic (CFRTP) components from carbon fiber on the premises of its Matsuyama Factory in Ehime Prefecture, Japan. The new plant will feature Teijin's unprecedented mass production technology for CFRTP components, which significantly reduces cycle times required for molding composite products to under a minute, enabling rapid production of various prototypes and performance evaluation tests.

    Construction of the new plant will begin shortly, with operations expected to commence in mid 2012. The new plant will enable Teijin to further accelerate its commercialization of CFRTP components for mass-produced automobiles and other industrial uses. Capital expenditure for the establishment of the pilot plant will total over two billion yen.
    Teijin's proprietary mass production technology for CFRTP enables the integrated production of carbon fiber to composite products within one minute, the ideal tact time required by automakers for mass-produced vehicles. The technology, which promises to realize revolutionary weight-reduction, is expected to find a wide range of applications in addition to automobiles, where certain levels of structural strength are required. CFRTP components are also highly recyclable, as technically its thermoplastic resins can be converted into desired shapes when heated.
    To introduce this cutting-edge technology to automakers, Teijin developed an electric-vehicle concept car earlier this year featuring a body structure made entirely of CFRTP components and weighing only 47 kilograms or roughly one-fifth the weight of a conventional automobile body structure.
    Through the new pilot plant, Teijin aims to accelerate its market development and further its position as a global leader in carbon fiber composite products.

    Fraunhofer IWU experts present new materials for additive manufacturing at their self-printed booth

    This year’s exhibits at Formnext focuse on materials particularly suited for aerospace applications but so far rarely used in LPBF (Laser Po...